ICU director granted 3,000-share RSU award

SeaStar Medical Holding Corp director equity grant: Director Jennifer A. Baird received an award of 3,000 shares of common stock on February 6, 2026, reported at a price of $0 per share.

Accepted by SEC EDGAR 02/10/2026 - 04:57 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

SeaStar Medical Holding Corp director equity grant: Director Jennifer A. Baird received an award of 3,000 shares of common stock on February 6, 2026, reported at a price of $0 per share. After this grant, she beneficially owns 6,620 shares of the company’s common stock in direct ownership.

The 3,000-share award is structured as restricted stock units (RSUs) that will vest in full on February 6, 2027, meaning the shares are subject to a one-year service-based vesting period before becoming fully owned and freely transferable, subject to any company trading policies.

Insider Trade Summary

Grant/Award: 3,000 shares

Grant/Award 1 txn

Insider Baird Jennifer A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.0001	3,000	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.0001 — 6,620 shares (Direct)

Footnotes (1)

1. F1. Represents a RSU award. The RSUs will vest in full on February 6, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ICU director Jennifer Baird report on this Form 4?

ICU director Jennifer A. Baird reported receiving 3,000 shares of SeaStar Medical common stock as an equity grant. The shares were acquired at a reported price of $0 per share and increase her beneficial ownership to 6,620 directly held shares following the transaction.

When did Jennifer Baird receive the 3,000 ICU shares and what type of award is it?

Jennifer Baird received the 3,000 SeaStar Medical shares on February 6, 2026 as a restricted stock unit (RSU) award. RSUs represent a promise of shares that are delivered once vesting conditions, typically continued service with the company, are satisfied.

When will Jennifer Baird’s 3,000 ICU RSUs vest according to the filing?

The filing states that Jennifer Baird’s 3,000 RSU award will vest in full on February 6, 2027. Once vested, the RSUs convert into common shares, giving her full ownership, subject to any applicable company trading windows or securities law restrictions.

How many SeaStar Medical (ICU) shares does Jennifer Baird own after this Form 4 transaction?

Following the RSU grant, Jennifer Baird beneficially owns 6,620 shares of SeaStar Medical common stock. The filing classifies this ownership as direct, indicating the shares are held in her name rather than through an intermediary entity like a trust or partnership.

Was there any cash consideration paid for the 3,000 ICU shares reported by Jennifer Baird?

The Form 4 shows a transaction price of $0 per share for the 3,000 ICU shares granted to Jennifer Baird. This reflects that the award was a compensatory equity grant rather than an open-market purchase, consistent with standard director compensation practices.

What role does Jennifer Baird hold at SeaStar Medical Holding Corp (ICU)?

Jennifer A. Baird is identified in the filing as a director of SeaStar Medical Holding Corp. She is not listed as an officer or a ten percent owner, indicating her reportable relationship to the company is through her board of directors position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baird Jennifer A

(Last) (First) (Middle)

3513 BRIGHTON BLVD

SUITE 410

(Street)

DENVER C0 80216

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SeaStar Medical Holding Corp [ ICU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001	02/06/2026		A		3,000(1)	A	$0	6,620	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a RSU award. The RSUs will vest in full on February 6, 2027.

	/s/ Eric Schlorff as-attorney-in-fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.